246 related articles for article (PubMed ID: 27693855)
1. TP53-induced glycolysis and apoptosis regulator protects from spontaneous apoptosis and predicts poor prognosis in chronic lymphocytic leukemia.
Hong M; Xia Y; Zhu Y; Zhao HH; Zhu H; Xie Y; Fan L; Wang L; Miao KR; Yu H; Miao YQ; Wu W; Zhu HY; Chen YY; Xu W; Qian SX; Li JY
Leuk Res; 2016 Nov; 50():72-77. PubMed ID: 27693855
[TBL] [Abstract][Full Text] [Related]
2. TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia.
Qian S; Li J; Hong M; Zhu Y; Zhao H; Xie Y; Huang J; Lian Y; Li Y; Wang S; Mao J; Chen Y
J Hematol Oncol; 2016 Nov; 9(1):128. PubMed ID: 27884166
[TBL] [Abstract][Full Text] [Related]
3. Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells.
López-Guerra M; Trigueros-Motos L; Molina-Arcas M; Villamor N; Casado FJ; Montserrat E; Campo E; Colomer D; Pastor-Anglada M
Haematologica; 2008 Dec; 93(12):1843-51. PubMed ID: 18945750
[TBL] [Abstract][Full Text] [Related]
4. Expression level of DEK in chronic lymphocytic leukemia is regulated by fludarabine and Nutlin-3 depending on p53 status.
Wang DM; Liu L; Fan L; Zou ZJ; Zhang LN; Yang S; Li JY; Xu W
Cancer Biol Ther; 2012 Dec; 13(14):1522-8. PubMed ID: 23052131
[TBL] [Abstract][Full Text] [Related]
5. Entinostat combined with Fludarabine synergistically enhances the induction of apoptosis in TP53 mutated CLL cells via the HDAC1/HO-1 pathway.
Zhou Z; Fang Q; Li P; Ma D; Zhe N; Ren M; Chen B; He Z; Wang J; Zhong Q; Wang J
Life Sci; 2019 Sep; 232():116583. PubMed ID: 31226417
[TBL] [Abstract][Full Text] [Related]
6. Identification of the TP53-induced glycolysis and apoptosis regulator in various stages of colorectal cancer patients.
Al-Khayal K; Abdulla M; Al-Obeed O; Al Kattan W; Zubaidi A; Vaali-Mohammed MA; Alsheikh A; Ahmad R
Oncol Rep; 2016 Mar; 35(3):1281-6. PubMed ID: 26675982
[TBL] [Abstract][Full Text] [Related]
7. Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis.
Wanka C; Steinbach JP; Rieger J
J Biol Chem; 2012 Sep; 287(40):33436-46. PubMed ID: 22887998
[TBL] [Abstract][Full Text] [Related]
8. TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells.
Peña-Rico MA; Calvo-Vidal MN; Villalonga-Planells R; Martínez-Soler F; Giménez-Bonafé P; Navarro-Sabaté À; Tortosa A; Bartrons R; Manzano A
Radiother Oncol; 2011 Oct; 101(1):132-9. PubMed ID: 21864926
[TBL] [Abstract][Full Text] [Related]
9. The BH3-only protein Puma plays an essential role in p53-mediated apoptosis of chronic lymphocytic leukemia cells.
Zhu HJ; Liu L; Fan L; Zhang LN; Fang C; Zou ZJ; Li JY; Xu W
Leuk Lymphoma; 2013 Dec; 54(12):2712-9. PubMed ID: 23517560
[TBL] [Abstract][Full Text] [Related]
10. Constitutively Photomorphogenic 1 Reduces the Sensitivity of Chronic Lymphocytic Leukemia Cells to Fludarabine Through Promotion of Ubiquitin-Mediated P53 Degradation.
Fu C; Shi X; Gong Y; Wan Y; Sun Z; Shi H; Wang Z; Marinaccio C; Crispino JD; Xu K
Cell Physiol Biochem; 2018; 50(6):2314-2328. PubMed ID: 30423551
[TBL] [Abstract][Full Text] [Related]
11. TIGAR, a p53-inducible regulator of glycolysis and apoptosis.
Bensaad K; Tsuruta A; Selak MA; Vidal MN; Nakano K; Bartrons R; Gottlieb E; Vousden KH
Cell; 2006 Jul; 126(1):107-20. PubMed ID: 16839880
[TBL] [Abstract][Full Text] [Related]
12. Impact of TP53-induced glycolysis and apoptosis regulator on malignant activity and resistance to ferroptosis in intrahepatic cholangiocarcinoma.
Toshida K; Itoh S; Iseda N; Izumi T; Yoshiya S; Toshima T; Ninomiya M; Iwasaki T; Oda Y; Yoshizumi T
Cancer Sci; 2024 Jan; 115(1):170-183. PubMed ID: 37878531
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic role of the TP53-induced glycolysis and apoptosis regulator in nasopharyngeal carcinoma through NF-κB pathway modulation.
Zhao M; Fan J; Liu Y; Yu Y; Xu J; Wen Q; Zhang J; Fu S; Wang B; Xiang L; Feng J; Wu J; Yang L
Int J Oncol; 2016 Feb; 48(2):756-64. PubMed ID: 26691054
[TBL] [Abstract][Full Text] [Related]
14. TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer.
Ko YH; Domingo-Vidal M; Roche M; Lin Z; Whitaker-Menezes D; Seifert E; Capparelli C; Tuluc M; Birbe RC; Tassone P; Curry JM; Navarro-Sabaté À; Manzano A; Bartrons R; Caro J; Martinez-Outschoorn U
J Biol Chem; 2016 Dec; 291(51):26291-26303. PubMed ID: 27803158
[TBL] [Abstract][Full Text] [Related]
15. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
[TBL] [Abstract][Full Text] [Related]
16. Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia.
Buchner M; Fuchs S; Prinz G; Pfeifer D; Bartholomé K; Burger M; Chevalier N; Vallat L; Timmer J; Gribben JG; Jumaa H; Veelken H; Dierks C; Zirlik K
Cancer Res; 2009 Jul; 69(13):5424-32. PubMed ID: 19549911
[TBL] [Abstract][Full Text] [Related]
17. Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans.
Xia Y; Fan L; Wang L; Gale RP; Wang M; Tian T; Wu W; Yu L; Chen YY; Xu W; Li JY
Oncotarget; 2015 Mar; 6(7):5426-34. PubMed ID: 25605254
[TBL] [Abstract][Full Text] [Related]
18. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia.
McElligott AM; Maginn EN; Greene LM; McGuckin S; Hayat A; Browne PV; Butini S; Campiani G; Catherwood MA; Vandenberghe E; Williams DC; Zisterer DM; Lawler M
Cancer Res; 2009 Nov; 69(21):8366-75. PubMed ID: 19826055
[TBL] [Abstract][Full Text] [Related]
19. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
[TBL] [Abstract][Full Text] [Related]
20. Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.
Rossi D; Fangazio M; Rasi S; Vaisitti T; Monti S; Cresta S; Chiaretti S; Del Giudice I; Fabbri G; Bruscaggin A; Spina V; Deambrogi C; Marinelli M; Famà R; Greco M; Daniele G; Forconi F; Gattei V; Bertoni F; Deaglio S; Pasqualucci L; Guarini A; Dalla-Favera R; Foà R; Gaidano G
Blood; 2012 Mar; 119(12):2854-62. PubMed ID: 22308293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
